JPH0959143A - Dermal preparation for external use containing 4-hydroxythiophenol - Google Patents

Dermal preparation for external use containing 4-hydroxythiophenol

Info

Publication number
JPH0959143A
JPH0959143A JP23753195A JP23753195A JPH0959143A JP H0959143 A JPH0959143 A JP H0959143A JP 23753195 A JP23753195 A JP 23753195A JP 23753195 A JP23753195 A JP 23753195A JP H0959143 A JPH0959143 A JP H0959143A
Authority
JP
Japan
Prior art keywords
hydroxythiophenol
external use
dermal preparation
oil
whitening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP23753195A
Other languages
Japanese (ja)
Inventor
Kenji Shimomura
健次 下村
Takahiro Tada
貴広 多田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mikimoto Pharmaceutical Co Ltd
Original Assignee
Mikimoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikimoto Pharmaceutical Co Ltd filed Critical Mikimoto Pharmaceutical Co Ltd
Priority to JP23753195A priority Critical patent/JPH0959143A/en
Publication of JPH0959143A publication Critical patent/JPH0959143A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a dermal preparation for external use excellent in beautifying and whitening actions. SOLUTION: This dermal preparation for external use comprises 4- hydroxythiophenol as an active ingredient and further a liquid oil such as squalane or jojoba oil, a solid oil such as beeswax or cetyl alcohol, various activators, a humectant such as glycerol or 1,3-butylene glycol or various agents are added thereto and formulated into the form such as a lotion, a cream, a milky lotion or a pack. The 4-hydroxythiophenol has stronger beautifying and whitening actions than those of kojic acid, arbutin, etc., and is extremely effectively used as the active ingredient of the dermal preparation for external use.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は美白に有効な物質に関す
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a substance effective for whitening.

【0002】[0002]

【従来の技術】美白作用をもった物質はすでに多くのも
のが知られている。製品化されたものにはコウジ酸、ア
ルブチンなどがある。しかし、効果が弱い等問題があっ
た。
2. Description of the Related Art Many substances having a whitening effect are already known. Commercialized products include kojic acid and arbutin. However, there were problems such as a weak effect.

【0003】[0003]

【発明が解決しようとする課題】本発明の目的は、皮膚
に適用して安全であると共に、美白作用が大きい皮膚外
用剤を提供することである。
SUMMARY OF THE INVENTION An object of the present invention is to provide a skin external preparation which is safe when applied to the skin and has a large whitening effect.

【0004】[0004]

【課題を解決する手段】本発明者らは、前記の課題を解
決するため、種々の物質をスクリーニングして調べ、化
粧品として利用価値のあるものを検討した。その結果、
4−ヒドロキシチオフェノールに着目し各種の実験を行
ったところ、美白作用が強いことが判明した。
[Means for Solving the Problems] In order to solve the above-mentioned problems, the present inventors have screened and examined various substances and examined those which are useful as cosmetics. as a result,
When various experiments were conducted focusing on 4-hydroxythiophenol, it was found that the whitening effect was strong.

【0005】すなわち、4−ヒドロキシチオフェノール
を含む皮膚外用剤である。
That is, it is a skin external preparation containing 4-hydroxythiophenol.

【0006】この物質を他の化粧品原料例えばスクワラ
ン、ホホバ油等の液状油、ミツロウ、セチルアルコール
等の固体油、各種の活性剤、グリセリン、1,3ブチレ
ングリコール等の保湿剤や各種薬剤等を添加してさまざ
まな剤形の皮膚外用剤を調整することができる。例えば
ローション、クリーム、乳液、パック等で目的に応じて
利用形態を考えればよい。
This substance is used as a raw material for other cosmetics such as liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various activators, humectants such as glycerin and 1,3 butylene glycol and various chemicals. It can be added to prepare various external forms of the skin external preparation. For example, a lotion, a cream, a milky lotion, a pack, or the like may be used depending on the purpose.

【0007】[0007]

【実施例】以下に実際の利用方法である実施例を記載す
るが、本発明はこの実施例によって何ら限定されるもの
ではない。
EXAMPLE An example of an actual usage will be described below, but the present invention is not limited to this example.

【0008】 実施例−1 ローション オリーブ油 0.5 4−ヒドロキシチオフェノール 0.2 ポリオキシエチレン(20E.0)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.0)硬化ヒマシ油 2.0 エタノール 10.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 精製水 80.3Example-1 Lotion Olive oil 0.5 4-Hydroxythiophenol 0.2 Polyoxyethylene (20E.0) sorbitan monostearate 2.0 Polyoxyethylene (60E.0) hydrogenated castor oil 2.0 Ethanol 10.0 1.0% sodium hyaluronate aqueous solution 5.0 Purified water 80.3

【0009】 実施例−2 クリーム A スクワラン 20.0 オリープ油 2.0 ミンク油 1.0 ホホバ油 5.0 ミツロウ 5.0 セトステアリルアルコール 2.0 グリセリンモノステアレート 1.0 ソルビタンモノステアレート 2.0 4−ヒドロキシチオフェノール 0.1 B 精製水 48.8 ポリオキシエチレン(20E.0)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.0)硬化ヒマシ油 1.0 グリセリン 5.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 パラオキシ安息香酸メチル 0.1 AとBをそれぞれ計量し、70℃まで加温し、BにAを
撹拌しつつ徐々に加えたのち、ゆっくり撹拌しつつ30
℃まで冷却した。
Example-2 Cream A Squalane 20.0 Oleip Oil 2.0 Mink Oil 1.0 Jojoba Oil 5.0 Beeswax 5.0 Cetostearyl Alcohol 2.0 Glycerin Monostearate 1.0 Sorbitan Monostearate 2 0.0 4-Hydroxythiophenol 0.1 B Purified water 48.8 Polyoxyethylene (20E.0) sorbitan monostearate 2.0 Polyoxyethylene (60E.0) hydrogenated castor oil 1.0 Glycerin 5.01 0.0% aqueous solution of sodium hyaluronate 5.0 Methyl paraoxybenzoate 0.1 Weigh A and B respectively, warm to 70 ° C., gradually add A to B with stirring, then slowly stir 30
Cooled to ° C.

【0010】チロシナーゼ活性阻害 (試験方法)30mMリン酸ナトリウム緩衝液(pH
6.8)0.9ml、0.05%ドーパ水溶液1.0m
l、検体のジメチルスルオキシド溶液の0.1ml、精
製水0.9mlをスクリューバイアルにとり、25℃恒
温水槽中で5分以上加温した。チロシナーゼ溶液(Si
gma社製、マッシュルーム由来、914ユニット/m
l)0.1mlを加え、25℃で恒温にしたセルに入
れ、30秒後より15秒ごとに3分間475nmで吸光
度を測定した。対照として、上記試料液のかわりにジメ
チルスルオキシドを加え同様に測定した。濃度を数段階
試験を行った。 (計算式) チロシナーゼ活性阻害率(%)=(B−A)/B×10
0 但し A:試料検体の吸光度の傾き B:対照の吸光度の傾き
Inhibition of tyrosinase activity (Test method) 30 mM sodium phosphate buffer (pH
6.8) 0.9 ml, 0.05% dopa aqueous solution 1.0 m
l, 0.1 ml of a dimethylsulfoxide solution of a sample, and 0.9 ml of purified water were placed in a screw vial, and heated in a constant temperature water bath at 25 ° C for 5 minutes or more. Tyrosinase solution (Si
gma, mushroom-derived, 914 units / m
l) 0.1 ml was added, the mixture was placed in a cell kept at a constant temperature of 25 ° C., and the absorbance was measured at 475 nm for 15 minutes every 15 seconds after 30 seconds. As a control, dimethylsulfoxide was added instead of the above sample solution, and the measurement was performed in the same manner. The concentration was tested in several steps. (Calculation formula) Tyrosinase activity inhibition rate (%) = (BA) / B × 10
0 where A: slope of absorbance of sample B: slope of absorbance of control

【0011】[0011]

【表1】 [Table 1]

【0012】B−16メラノーマ細胞試験 検体を所定の濃度になるように、EaglesMEM培
地に加え、除菌フィルターでろ過後、牛胎児血清が10
%なるように加え、pHを7.6±0.1になるように
炭酸水素ナトリウムで調整し、シャーレに6ml分注
し、B−16メラノーマ細胞浮遊液(1×10cel
l/ml)を0.05ml加え、5%CO、95%a
irの条件下で37℃で3日間培養した。さらに、培地
交換(上記の検体が入った10%牛胎児血清含有Eag
lesMEM培地)を行い、3日間培養した。(このと
き、細胞増殖を判定する) 細胞を剥離し、遠心分離して、細胞を集め、肉眼で白色
度の判定を行った。 白色度 ブランクと同程度 ± わずかに白色化傾向 + 明らかに白色化傾向 ++ 強い白色化傾向 +++ 細胞増殖 ブランクの80%以上 A ブランクの60〜80% B ブランクの30〜60% C ブランクの30%以下 D
B-16 melanoma cell test A sample was added to Eagle's MEM medium to a predetermined concentration and filtered through a sterilization filter.
% So that the pH was adjusted to 7.6 ± 0.1 with sodium hydrogen carbonate, and 6 ml was dispensed into a petri dish, and the B-16 melanoma cell suspension (1 × 10 6 cells) was added.
1 / ml), 5% CO 2 , 95% a
The cells were cultured under ir conditions at 37 ° C for 3 days. In addition, exchange the medium (Eag containing 10% fetal bovine serum containing the above sample)
lesMEM medium) and cultured for 3 days. (At this time, cell proliferation was determined.) The cells were peeled off, centrifuged, the cells were collected, and the whiteness was visually determined. Brightness Same as blank ± Slight whitening tendency + Clear whitening tendency ++ Strong whitening tendency +++ Cell proliferation 80% or more of blank A 60-80% of blank B 30-60% of blank C 30% of blank Below D

【0013】[0013]

【表2】 [Table 2]

【0014】使用テスト 女性8名の顔面を左右に分け、一方を実施例、もう一方
を比較例として毎日、1回以上使用してもらって、3月
後、アンケートした。なお、比較例は実施例より製造例
を水にかえたものである。(比較例1,2) 判定基準は以下のようでアンケートの結果をまとめたの
が以下の表である。 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例の方がかなりよい −2 比較例の方が非常によい −3
Use Test Eight women's faces were divided into right and left sides, one of which was used as an example and the other was used as a comparative example once or more daily, and a questionnaire was conducted after 3 months. In the comparative example, the production example was changed to water from the example. (Comparative Examples 1 and 2) The criteria are as follows, and the results of the questionnaire are summarized in the table below. Example is much better 3 Example is much better 2 Example is slightly better 1 No difference 0 Comparative example is slightly better -1 Comparative example is much better -2 Comparative example Is much better -3

【0015】 [0015]

【0016】[0016]

【効果】4−ヒドロキシチオフェノールはコウジ酸等に
比較して美白作用が強く、皮膚外用剤の有効成分として
非常に有効である。
[Effect] 4-Hydroxythiophenol has a stronger whitening effect than kojic acid and the like, and is very effective as an active ingredient of a skin external preparation.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 4−ヒドロキシチオフェノールを含む皮
膚外用剤
1. An external preparation for skin containing 4-hydroxythiophenol.
JP23753195A 1995-08-10 1995-08-10 Dermal preparation for external use containing 4-hydroxythiophenol Pending JPH0959143A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23753195A JPH0959143A (en) 1995-08-10 1995-08-10 Dermal preparation for external use containing 4-hydroxythiophenol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23753195A JPH0959143A (en) 1995-08-10 1995-08-10 Dermal preparation for external use containing 4-hydroxythiophenol

Publications (1)

Publication Number Publication Date
JPH0959143A true JPH0959143A (en) 1997-03-04

Family

ID=17016723

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23753195A Pending JPH0959143A (en) 1995-08-10 1995-08-10 Dermal preparation for external use containing 4-hydroxythiophenol

Country Status (1)

Country Link
JP (1) JPH0959143A (en)

Similar Documents

Publication Publication Date Title
KR100361433B1 (en) Anti-aging cosmetic compositions containing an Extract obtained from Panax ginseng
JP3558349B2 (en) Whitening cosmetics
JPH0977655A (en) Skin preparation for external use
JPH01275511A (en) External drug for skin
JPH0892053A (en) External preparation for skin
JP3611675B2 (en) Topical skin preparation
JPH0959143A (en) Dermal preparation for external use containing 4-hydroxythiophenol
JPH10212225A (en) Wrinkle preventive
JPH0925212A (en) Skin preparation for external use
JP3505003B2 (en) External preparation
JP3101090B2 (en) External preparation for skin
EP0795319A1 (en) Compositions for fair-skin
JPH04356409A (en) Cosmetic
JP4223574B2 (en) Cosmetic composition for whitening
JP3548988B2 (en) External preparation for skin
EP0503763A1 (en) Cosmetic material
JP3113009B2 (en) Whitening cosmetics
JP2003252743A (en) Tyrosinase activity inhibitor, melanogenesis inhibitor and skin care preparation containing them
JPH10109925A (en) Beautifying and whitening cosmetic
JP3452393B2 (en) Cosmetics
EP0422466A1 (en) Endermic preparation of external application
JPH10120549A (en) Fair cosmetic
JPH0597649A (en) Cosmetic
JP3354031B2 (en) External preparation for skin
JPH04124115A (en) External preparation

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040218

A131 Notification of reasons for refusal

Effective date: 20040302

Free format text: JAPANESE INTERMEDIATE CODE: A131

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20040511